Elevated levels of matrix metalloproteinases-9 and-1 and of tissue inhibitors of MMPs, TIMP-1 and TIMP-2 in postmortem brain tissue of progressive supranuclear palsy

被引:24
作者
Lorenzl, S
Albers, DS
Chirichigno, JW
Augood, SJ
Beal, MF
机构
[1] Cornell Univ, Weill Med Coll, Dept Neurol & Neurosci, New York, NY 10021 USA
[2] Massachusetts Gen Hosp, Neurol Serv, Boston, MA 02114 USA
[3] Harvard Univ, Sch Med, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
matrix metalloproteinases; supranuclear palsy; substantia nigra;
D O I
10.1016/j.jns.2003.10.015
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We determined the levels and tissue localization of matrix metalloproteinases (MMPs) as well as their endogenous tissue inhibitors (TIMPs) in postmortem brain tissue from 13 patients with progressive supranuclear palsy (PSP) and 8 age-matched controls. MMP-9 expression was significantly increased in both the frontal cortex (p = 0.002) and substantia nigra (p = 0.003) of PSP cases as compared to controls whereas MMP-1 levels were increased in the substantia nigra (p = 0.01) but unchanged in the frontal cortex (p = 0.41). Levels of the endogenous tissue inhibitors of MMPs, TIMP-1 and TIMP-2 were significantly elevated in the substantia nigra (TIMP-1: p = 0.004, TIMP-2: p = 0.01). Levels of TIMPs were unchanged in PSP frontal cortex as compared to control cases. Together, these data show alterations of MMPs and TIMPs in the substantia nigra as well as in the frontal cortex of PSP, consistent with the possibility that alterations in MMPs/TIMPs may contribute to disease pathogenesis. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:39 / 45
页数:7
相关论文
共 35 条
[1]   Frontal lobe dysfunction in progressive supranuclear palsy: Evidence for oxidative stress and mitochondrial impairment [J].
Albers, DS ;
Augood, SJ ;
Park, LCH ;
Browne, SE ;
Martin, DM ;
Adamson, J ;
Hutton, M ;
Standaert, DG ;
Vonsattel, JPG ;
Gibson, GE ;
Beal, MF .
JOURNAL OF NEUROCHEMISTRY, 2000, 74 (02) :878-881
[2]   New insights into progressive supranuclear palsy [J].
Albers, DS ;
Augood, SJ .
TRENDS IN NEUROSCIENCES, 2001, 24 (06) :347-352
[3]  
Asahina M, 2001, CLIN NEUROPATHOL, V20, P60
[4]  
Augood SJ, 2000, J COMP NEUROL, V421, P247
[5]   CHARACTERIZATION OF NEUTRAL PROTEINASES FROM ALZHEIMER-AFFECTED AND CONTROL BRAIN SPECIMENS - IDENTIFICATION OF CALCIUM-DEPENDENT METALLOPROTEINASES FROM THE HIPPOCAMPUS [J].
BACKSTROM, JR ;
MILLER, CA ;
TOKES, ZA .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (03) :983-992
[6]   Association of an extended haplotype in the tau gene with progressive supranuclear palsy [J].
Baker, M ;
Litvan, I ;
Houlden, H ;
Adamson, J ;
Dickson, D ;
Perez-Tur, J ;
Hardy, J ;
Lynch, T ;
Bigio, E ;
Hutton, M .
HUMAN MOLECULAR GENETICS, 1999, 8 (04) :711-715
[7]   Matrix metalloproteinase-9 is elevated in serum of patients with amyotrophic lateral sclerosis [J].
Beuche, W ;
Yushchenko, M ;
Mäder, M ;
Maliszewska, M ;
Felgenhauer, K ;
Weber, F .
NEUROREPORT, 2000, 11 (16) :3419-3422
[8]   Expression and activity of antioxidants in the brain in progressive supranuclear palsy [J].
Cantuti-Castelvetri, I ;
Keller-McGandy, CE ;
Albers, DS ;
Beal, MF ;
Vonsattel, JP ;
Standaert, DG ;
Augood, SJ .
BRAIN RESEARCH, 2002, 930 (1-2) :170-181
[9]   Increased gelatinase A (MMP-2) and gelatinase B (MMP-9) activities in human brain after focal ischemia [J].
Clark, AW ;
Krekoski, CA ;
Bou, SS ;
Chapman, KR ;
Edwards, DR .
NEUROSCIENCE LETTERS, 1997, 238 (1-2) :53-56
[10]   Astroglial permissivity for neuritic outgrowth in neuron-astrocyte cocultures depends on regulation of laminin bioavailability [J].
Costa, S ;
Planchenault, T ;
Charriere-Bertrand, C ;
Mouchel, Y ;
Fages, C ;
Juliano, S ;
Lefrançois, T ;
Barlovatz-Meimon, G ;
Tardy, M .
GLIA, 2002, 37 (02) :105-113